Sunday, February 10, 2019

included in the efficacy analysis

The reasons for the discontinuation included sesame oil vehicle allergy, hepatotoxicity, excessive sleepiness and poor efficacy, gastrointestinal intolerance, worsening of seizures and hyperammonaemia CBD Gummies. In addition, 25 (15%) patients included in the safety analysis were not included in the efficacy analysis. The most frequent epileptic syndromes treated were Dravet Syndrome and Lennox-Gastaut Syndrome.

Titration was performed up to a maximum dose of 50 mg / kg / day in 48 (30%) patients, 23 of whom received a dose of more than 25 mg / kg / day during the 12 weeks of the observation period; only 19 patients were receiving> 25 mg / kg / day in the week 12 consultation.

No comments:

Post a Comment